|Articles|June 8, 2020
Clinical Trials in the Wake of COVID-19
ACT’s Lisa Henderson interviews John Potthoff, PhD, CEO of Elligo Health Research, about decentralizing and restarting clinical trials amid the COVID-19 pandemic.
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access
2
Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection
3
Artificial Intelligence in Clinical Trials: From Pilots to Practice
4
ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion
5